atovaquone has been researched along with Complication, Postoperative in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barr, VO; Galal, A; McLaughlin, MM; Mitchell, P; Patel, N; Richardson, CL; Stosor, V; Sutton, SH | 1 |
Ananthanarayanan, V; Fedson, S; Husain, AN; Kim, G; Murks, C; Petty, LA; Potter, L; Pursell, K; Qamar, S | 1 |
Cockfield, S; Gourishankar, S; Humar, A; Kumar, D; Mueller, T; Vethanayagam, D; Weinkauf, J | 1 |
3 other study(ies) available for atovaquone and Complication, Postoperative
Article | Year |
---|---|
Switch to atovaquone and subsequent re-challenge with trimethoprim-sulfamethoxazole for Pneumocystis prophylaxis in a kidney transplant population.
Topics: Adult; Anti-Infective Agents; Antibiotic Prophylaxis; Atovaquone; Drug Substitution; Humans; Kidney Transplantation; Pneumocystis carinii; Pneumonia, Pneumocystis; Postoperative Complications; Retrospective Studies; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2017 |
Cardiac toxoplasmosis after heart transplantation diagnosed by endomyocardial biopsy.
Topics: Adult; Anti-Infective Agents; Atovaquone; Biopsy; Heart Transplantation; Humans; Male; Myocardium; Postoperative Complications; Toxoplasmosis | 2015 |
Pneumocystis jirovecii pneumonia after rituximab therapy for antibody-mediated rejection in a renal transplant recipient.
Topics: Anti-Infective Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Atovaquone; Female; Graft Rejection; Humans; Immunologic Factors; Injections, Intravenous; Kidney Transplantation; Middle Aged; Pneumocystis carinii; Pneumonia, Pneumocystis; Postoperative Complications; Radiography; Rituximab; Tomography Scanners, X-Ray Computed; Treatment Outcome; Trimethoprim | 2009 |